StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.06−0.44 (-12.57%)

Close on Nov 18, 2026Market cap $62.83KP/E –Yield –

Addex Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Addex Therapeutics's market cap was $63.15K on Nov 11, 2026, against $150.30K a year earlier. Over the last 5 years it ranged from $60.30K to $559.00K, with a median of $141.89K.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$63.15K-58.3%
2025Dec 31, 2025$151.39K+24.4%
2024Dec 31, 2024$121.72K+56.9%
2023Dec 29, 2023$77.60K+17.0%
2022Dec 30, 2022$66.29K-86.0%
2021Dec 31, 2021$473.83K-52.2%
2020Dec 31, 2020$990.30K–

More Addex Therapeutics figures

See a number that looks wrong?